Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bertolus

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|January 13, 2026
Diagnosis and management of orbital compartment syndrome caused by retrobulbar hematoma following orbital fracturesF Bourquard, J P Foy, Q Hennocq, et al.
AJNR. American Journal of Neuroradiology|September 25, 2020
Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous <sup>18</sup>F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer?N Pyatigorskaya, R De Laroche, G Bera, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|March 9, 2006
[Management of mandibular ameloblastoma]P Bouletreau, A-R Paranque, M Steve, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 26, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelinesS Vergez, S Morinière, F Dubrulle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockadeJ-P Foy, C Bertolus, M-C Michallet, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|January 13, 2026
Diagnosis and management of orbital compartment syndrome caused by retrobulbar hematoma following orbital fracturesF Bourquard, J P Foy, Q Hennocq, et al.
AJNR. American Journal of Neuroradiology|September 25, 2020
Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous <sup>18</sup>F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer?N Pyatigorskaya, R De Laroche, G Bera, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|March 9, 2006
[Management of mandibular ameloblastoma]P Bouletreau, A-R Paranque, M Steve, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 26, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelinesS Vergez, S Morinière, F Dubrulle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockadeJ-P Foy, C Bertolus, M-C Michallet, et al.
Pageof 4